Commonwealth Biotechnologies, Inc. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Commonwealth Biotechnologies, Inc. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Commonwealth Biotechnologies, Inc.. The Group's principal activity is to provide solutions to the global biotechnology industry, academic institutions, genetic identity, laboratory services, commercial contracts, government agencies and pharmaceutical companies. It provides integrated contract research support in four principal areas: bio-defense; laboratory support services for on-going clinical trials; comprehensive contract projects in the private sector; and through it FIL division, for paternity testing, forensic case-work analysis and CODIS work. The Group also provides sophisticated macromolecular synthetic and analytical services, integrating individual platform technologies. The Group facilitates strategic decisions to both short term and long term clients. It operates only in the United States. On 23-Sep-2008, the Group discontinued Exelgen Limited.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report